# Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC)

> **NCT02321917** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 50 (actual)

## Conditions studied

- Extracorporeal Circulation
- Inflammation
- Blood Coagulation
- Intracranial Embolism

## Interventions

- **DEVICE:** MECC system with rheoparin coating

## Key facts

- **NCT ID:** NCT02321917
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2019-11
- **Final completion:** 2019-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02321917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02321917, "Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02321917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*